204
Participants
Start Date
March 31, 2009
Primary Completion Date
July 31, 2015
lapatinib ditosylate
Given orally
Placebo
Given orally
Barts and the London NHS Trust, London
NHS Grampian - Aberdeen Royal Infirmary, Aberdeen
Basildon and Thurrock University Hospital NHS Trust - Basildon Hospital, Basildon
University Hospitals Birmingham NHS Foundation Trust - Birmingham University Hospital, Birmingham
Royal Bournemouth and Christchurch NHS Foundation Trust - Royal Bournemouth Hospital, Bournemouth
University Hospitals Bristol NHS Trust - Bristol University Hospital, Bristol
Cambridge University Hospitals NHS Trust - Addenbrooke's Hospital, Cambridge
Mid Essex NHS Trust - Broomfield Hospital, Chelmsford
Colchester University Hospitals NHS Trust, Colchester
University Hospitals Coventry & Warwickshire NHS Trust, Coventry
Derby Hospitals NHS Trust - Royal Derby Hospital, Derby
NHS Greater Glasgow and Clyde - The Beatson, Glasgow
Calderdale and Huddersfield NHS Trust - Huddersfield Royal Infirmary, Huddersfield
Ipswich Hospital NHS Trust, Ipswich
University Hospitals of Leicester NHS Trust, Leicester
Clatterbridge Centre for Oncology NHS Trust, Liverpool
Guys & St Thomas' Hospital NHS Trust - Guys Hospital, London
Imperial Healthcare NHS Trust, London
Royal Marsden NHS Trust, London
South Tees NHS Trust - James Cook University Hospital, Middlesbrough
Newcastle Upon Tyne Hospitals NHS Trust, Newcastle
Northampton General Hospitals NHS Trust, Northampton
Nottingham University Hospitals NHS Trust, Nottingham
Sherwood Forest Hospitals NHS Trust - Kings Mill Hospital, Nottingham
Portsmouth Hospitals NHS Trust - Queen Alexandra Hospital, Portsmouth
Barking, Havering and Redbridge NHS Trust - Queens Hospital, Romford
Taunton and Somerset NHS Trust - Musgrove Park Hospital, Taunton
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Queen Mary University of London
OTHER